Welcome to our dedicated page for Walgreens Boots Alliance news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreens Boots Alliance stock.
Walgreens Boots Alliance, Inc. became a privately owned company after Sycamore Partners completed its acquisition of WBA in August 2025. News about the former public issuer centers on the transition of Walgreens and related businesses under private ownership, including Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD.
Recurring company updates also cover Walgreens' U.S. retail pharmacy and health-services operations, specialty pharmacy limited-distribution drug relationships, and capital actions tied to WBA and Walgreen Co. senior notes, including tender offers and consent solicitations.
Walgreens is partnering with CAMP to offer limited-edition Ultimate Beach Day Bundles to families nationwide, promoting sun safety and summer fun. Starting August 5, families can reserve these free bundles featuring Walgreens brand health products. On August 11, an event in Domino Park, Brooklyn, will include activities like a treasure hunt and beach yoga. One bundle hides a grand prize for a beach vacation. Walgreens emphasizes their commitment to health and wellness through this initiative, showcasing their range of pharmacist-recommended products.
Walgreens Boots Alliance (WBA) has announced a quarterly dividend of 48 cents per share, marking a 0.5% increase from the previous rate. This dividend is set to be paid on September 9, 2022, to stockholders of record as of August 19, 2022. The annual dividend rate has risen from $1.91 to $1.92 per share. WBA has consistently paid dividends for over 89 years and has increased them for 47 consecutive years, reflecting the company's longstanding commitment to returning value to its shareholders.
Walgreens Boots Alliance (WBA) reported third-quarter fiscal 2022 results, with EPS from continuing operations down 73.8% to $0.33, compared to $1.27 last year. Adjusted EPS decreased 30.0% to $0.96. Sales fell 4.2% to $32.6 billion, reflecting a significant impact from AllianceRx Walgreens. Operating income showed a loss of $320 million, compared to a gain of $1.1 billion last year. Despite these challenges, retail comparable sales grew 2.4%, and Walgreens Health pro forma sales surged 65%. The company aims for $3.5 billion in annual cost savings by fiscal 2024.
Walgreens Boots Alliance (WBA) has decided to retain its Boots and No7 Beauty Company businesses after a strategic review initiated in January. Despite considerable interest from buyers, the ongoing instability in global financial markets hindered potential offers. WBA is focusing on the continued growth of Boots and No7, which have shown strong performance. CEO Rosalind Brewer noted the necessity of this decision amid challenging conditions, emphasizing the potential for future opportunities in the healthcare and beauty sectors.
Summary not available.
Walgreens is expanding its Health Corner services to over 2.27 million patients across California, New Jersey, and Ohio by summer's end. This initiative is part of a collaboration with Buckeye Health Plan to provide health services to Medicaid members in northeast Ohio. Walgreens Health Corners will enhance access to healthcare, offering services like health screenings, chronic condition management, and personalized care by Health Advisors. The number of locations will grow from 55 to about 100 by the end of 2022.
Walgreens will start administering Pfizer and Moderna COVID-19 vaccines to children aged 3 and older at select locations starting Saturday, June 25. This follows FDA Emergency Use Authorization and CDC guidance for vaccinating younger children. Parents are encouraged to schedule appointments via Walgreens.com or the Walgreens app. Walgreens pharmacists, experienced in pediatric immunizations, aim to provide comfort and education for families during the vaccination process. Notably, Walgreens has extensive experience in administering vaccines to millions of children and adolescents.
Walgreens and Greater Than AIDS are hosting the largest National HIV Testing Day event in over 250 cities on June 27, aiming to increase awareness and access to HIV testing. This initiative addresses a decline in testing during the COVID-19 pandemic, where about 13% of the 1.2 million people living with HIV in the U.S. are unaware of their status. The event will provide free, confidential testing at participating Walgreens locations, supported by local health departments and community organizations.
Wile, a wellness brand focused on midlife women's health, is set to launch four herbal supplement capsules at Walgreens this month. Aimed at women aged 40+, these products target common hormonal symptoms like stress and night sweats. Wile's holistic approach, developed with naturopathic doctors, includes the 40+ Perimenopause Support, 40+ Period Support, Hot Flash, and Women’s Stress supplements, all retailing for $39.99. This partnership highlights Wile's goal to enhance visibility and accessibility in midlife women’s health, reinforcing the role of community pharmacies in healthcare.
Walgreens Boots Alliance (WBA) will announce its fiscal 2022 third quarter earnings on June 30, 2022, at 7 a.m. ET, followed by a conference call at 8:30 a.m. ET. The event will be available live on the WBA investor relations website, with a replay accessible for 12 months. WBA, a global leader in pharmacy and healthcare, operates around 13,000 locations across the U.S., Europe, and Latin America, committed to improving health services and promoting sustainability. The company employs over 315,000 people and has a diverse portfolio of consumer and healthcare-focused brands.